DCBLD1 and head and neck squamous cell carcinoma: Based on significant differences (adjusted p-value < 0.05, FDR < 0.25), GSEA was used to identify signaling pathways associated with HNSCC between the high and low DCBLD1 expression groups, including 102 positive regulation pathways and 74 negative regulation pathways.